Filing Details
- Accession Number:
- 0001209191-19-000918
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-03 16:19:16
- Reporting Period:
- 2018-12-31
- Accepted Time:
- 2019-01-03 16:19:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438133 | Tandem Diabetes Care Inc | TNDM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1365369 | F John Sheridan | C/O Tandem Diabetes Care, Inc., 11075 Roselle Street San Diego CA 92121 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-12-31 | 788 | $37.81 | 666 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-01-02 | 20,000 | $2.59 | 20,666 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-01-02 | 4,599 | $36.23 | 16,067 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-01-02 | 15,401 | $35.51 | 666 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2019-01-02 | 20,000 | $0.00 | 20,000 | $2.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
80,000 | 2027-12-01 | No | 4 | M | Direct |
Footnotes
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $37.75 and $37.85.
- Represents shares of common stock received upon exercise of a stock option award.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $36.04 and $36.55.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $35.02 and $35.87.
- Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter